<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02064699</url>
  </required_header>
  <id_info>
    <org_study_id>I10002 QUANTIC-R+</org_study_id>
    <nct_id>NCT02064699</nct_id>
  </id_info>
  <brief_title>Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.</brief_title>
  <acronym>QUANTIC-R+</acronym>
  <official_title>Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cytomegalovirus (CMV) infection was observed in over 30% of organ recipients with high
      morbidity. Moreover, no prophylaxis, 75% R + D-transplanted, 55%, R + D + and D-25% R +
      develop CMV. The number of available antiviral drugs is reduced and noticeable side effects
      (neutropenia, renal toxicity) lead to premature discontinuation of therapy or the use of
      reduced doses that promote non-response to treatment and the emergence of resistance. In case
      of neutropenia, there are more an increased risk of secondary rejection due to the reduction
      of immunosuppressive treatment rendered necessary by the haematological reached.

      Rational use of these molecules is necessary with essential today as the optimal duration of
      prophylaxis primary issues and the prophylaxis of recurrences in case of CMV infection
      reported in.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      QuantiFERON-CMV ® is a fast and standardized test that evaluates the CMV specific cellular
      immunity measuring the amount of secreted Interferon gamma (IFN gamma) in plasma by ELISA. It
      uses more epitopes of proteins including CMV glycoprotein B (gB), protein IE-1 and protein
      pp65 and protein pp50, which are specific for (human leukocyte antigen) HLA class I.
      Pretreatment of the sample is simple and plasma can be stored, frozen, for a delayed dose of
      interferon.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">May 2013</start_date>
  <completion_date type="Actual">December 13, 2017</completion_date>
  <primary_completion_date type="Actual">December 13, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predictive values of Cytomegalovirus infection</measure>
    <time_frame>1 week</time_frame>
    <description>CMV infection defined by a positive ADNémie confirmed on a second sample ideally one week apart.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>No response to treatment</measure>
    <time_frame>21 days</time_frame>
    <description>Persistence of an active CMV infection defined by a persistent ADNémie for more than 21 days under antiviral treatment.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Renal Transplant Recipient</condition>
  <condition>Immunized Against the Cytomegalovirus</condition>
  <arm_group>
    <arm_group_label>CMV infection</arm_group_label>
    <description>Renal transplant recipient immunized against the Cytomegalovirus</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CMV Infection</intervention_name>
    <description>Routine follow-up (viral load, creatininaemia, neutrophil count, isolation of CMV strains when possible) and biological sample collection for.
Using the QuantiFERON-CMV test for predicting the risk of CMV infection in the transplanted immune against CMV.</description>
    <arm_group_label>CMV infection</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Detection of the CMV in sang, the leukocytes, or plasma with or without the viral
      quantification.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Renal transplant recipient Immunized against the Cytomegalovirus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Renal transplant recipient

          -  Immunized against the Cytomegalovirus

        Exclusion Criteria:

          -  Not willing to participate, no health insurance

          -  clinical evidence of active viral infection

          -  renal transplant recipient whose treatment includes induction antilymphocyte
             antibodies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophie ALAIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Limoges UH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Besancon</city>
        <zip>25</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Caen</city>
        <zip>14</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Grenoble</city>
        <zip>38</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Lille</city>
        <zip>59</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bactériologie Virologie</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Nantes</city>
        <zip>44</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Reims</city>
        <zip>51</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Rennes</city>
        <zip>35</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virologie</name>
      <address>
        <city>Strasbourg</city>
        <zip>67</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foch Hospital</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2014</study_first_submitted>
  <study_first_submitted_qc>February 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2014</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Renal transplant</keyword>
  <keyword>CMV</keyword>
  <keyword>Test QuantiFERON-CMV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cytomegalovirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

